$PHIN

Gustanski Christopher sold $140K of PHIN

Gustanski Christopher (VP, Operational Excellence) sold 2,097 shares of PHINIA INC. (PHIN) at $66.96 ($0.14M total) on 2026-09-09.

Original reporting
SEC EDGAR · Gustanski Christopher
Published Sep 11, 2026, 8:16 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 11, 2026, 8:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PHIN
Neutral
high confidence
Mentioned
$PHIN
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PHINNeutralLow
01

Why it matters

The transaction is a routine insider sell with limited market impact.

02

Market read

Minor insider sell; unlikely to affect broader market sentiment.

03

What to watch

No other material corporate events disclosed; the sale is routine.

Relevance 4/10Novelty 4/10Timing: filed today

Background

SEC Form 4 filing discloses insider transactions; this is the first public report of this sale.

Company-level read

Ticker impact

$PHINNeutralHigh confidence
Context

VP Christopher Gustanski sold 2,097 shares for $140,425, reducing his stake to 11,301 shares.

Expected impact

minimal impact, possible slight downward pressure

Evidence & confidence

The sale size (~$140k) is small relative to market cap and typical insider activity, so traders should not expect significant price movement.

Market effects

none

none

none

Counterpoint

If the insider has private negative information, the sell could foreshadow a short-term dip.

Key entities

  • PHINIA INC.

    Biopharma company whose ticker is PHIN.

  • Christopher Gustanski

    Vice President of Operational Excellence at PHINIA.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PHINMed

Phinia (PHIN) Q2 2026 Earnings Call Transcript

Phinia (PHIN) reported Q2 2026 results on an earnings call. Net sales were $940 million, up 5.6% year over year, with adjusted EBITDA of $130 million (13.8% margin) and adjusted EPS $1.53 (up 20.5%). Cash was $370 million, liquidity $820 million, net leverage 1.3x. The company returned $53 million via buybacks and dividends.

$PHINMedAI 8/10

PHINIA Inc. Q2 2026 Earnings Call Summary

PHINIA’s Q2 2026 call cited 5.6% revenue growth driven by Fuel Systems and Aftermarket demand. Adjusted EPS rose 20.5%. Full-year 2026 revenue guidance was refined to $3.57B-$3.67B and adjusted EBITDA to $485M-$515M. Free cash flow was raised to $210M-$250M. The stoba Group acquisition is expected to close in Q4 2026.

$PHINHighAI 9/10

Phinia (PHIN) Q2 2026 Earnings Call Transcript

Thursday, July 30, 2026, at 8:30 a.m. ET CALL PARTICIPANTS Vice President and Treasurer - Gordon Muir Chief Executive Officer - Brady Ericson Chief Financial Officer - Chris Gropp TAKEAWAYS Net Sales -- $940 million, growing 5.6% year over year driven by volume growth in both the Fuel Systems and Aftermarket segments. Fuel Systems Sales -- $584 million, a 5% increase year over year reflecting steady demand in key end markets.

$PHINMed

PHINIA REPORTS SECOND QUARTER 2026 RESULTS

PHINIA INC. (PHIN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 PHINIA REPORTS SECOND QUARTER 2026 RESULTS Auburn Hills, Michigan, July 30, 2026 – PHINIA Inc. (NYSE: PHIN), a diversified, industrial supplier and global leader in the development of fuel systems, electrical systems, and aftermarket solutions, today reported results